Mycobacterium mucogenicum
Mycobacterium mucogenicum is a species of bacteria belonging to the genus Mycobacterium. It is a rapidly growing, non-tuberculous mycobacterium (NTM) that is found in the environment, particularly in water sources.
History and Classification[edit]
Mycobacterium mucogenicum was first isolated and described in 1982. It was initially classified as a member of the Mycobacterium fortuitum complex, but was later reclassified as a distinct species due to differences in its genetic and phenotypic characteristics.
Characteristics[edit]
Mycobacterium mucogenicum is a Gram-positive, acid-fast bacterium. It is a non-motile, non-spore-forming rod that grows rapidly in culture, typically within 3-5 days. The bacterium is capable of surviving in a wide range of environmental conditions, including both water and soil.
Pathogenicity[edit]
While Mycobacterium mucogenicum is primarily an environmental organism, it can also cause disease in humans, particularly in individuals with weakened immune systems. Infections caused by this bacterium are often associated with exposure to contaminated water sources. The bacterium has been implicated in a range of clinical conditions, including skin and soft tissue infections, pulmonary disease, bacteremia, and catheter-related infections.
Diagnosis and Treatment[edit]
Diagnosis of Mycobacterium mucogenicum infection typically involves culture of the organism from clinical specimens, followed by identification using molecular techniques. Treatment usually involves a combination of antibiotics, with the specific regimen determined based on the susceptibility profile of the isolate.
See Also[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian